News Release

Zogenix to Release Fourth Quarter and Full-Year 2018 Financial Results and Host Conference Call and Webcast on February 28


EMERYVILLE, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2018, after the market close, and will host a corporate update conference call and webcast on Thursday, February 28, 2019, at 4:30 PM Eastern Time.

Conference Call Details
Thursday, February 28 @ 4:30 PM Eastern Time/1:30 PM Pacific Time
Toll Free: 877-407-9716 
International: 201-493-6779
Conference ID: 13687457


Replays available through March 14:
Domestic: 844-512-2921
International: 412-317-6671
Replay PIN: 13687457

About Zogenix
Zogenix is a global pharmaceutical company committed to developing and commercializing transformative therapies to improve the lives of patients and their families living with rare diseases. For more information, visit


Melinda Baker
Senior Director, Corporate Communications

Andrew McDonald
Founding Partner, LifeSci Advisors LLC
+1 (646) 597-6987 |




Source: Zogenix, Inc.